Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kamen, DL"" wg kryterium: Autor


Tytuł:
Cultural and quality-of-life considerations when administering corticosteroids as a therapeutic strategy for African American women living with systemic lupus erythematosus
Autorzy:
Applyrs DL
Williams EM
Faith TD
Kamen DL
Vazquez E
Jurkowski JM
Pokaż więcej
Temat:
Systemic lupus erythematosus
African American
women
corticosteroids
quality of life
Medicine (General)
R5-920
Źródło:
Patient Preference and Adherence, Vol Volume 12, Pp 1007-1014 (2018)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/cultural-and-quality-of-life-considerations-when-administering-cortico-peer-reviewed-article-PPA; https://doaj.org/toc/1177-889X
Dostęp URL:
https://doaj.org/article/e1c6f2bbbb7243008170530edbce8c4c  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.
Autorzy:
Young, KA
Terrell, DR
Guthridge, JM
Kamen, DL
Gilkeson, GS
Karp, DR
Ishimori, ML
Weisman, MH
Holers, VM
Harley, JB
Norris, JM
James, JA
Pokaż więcej
Temat:
SYSTEMIC lupus erythematosus
SMOKING
AUTOIMMUNE diseases
VASCULAR diseases
DISEASE statistics
Źródło:
Lupus; Apr2014, Vol. 23 Issue 4, p360-369, 10p, 3 Charts, 2 Graphs
Czasopismo naukowe
Tytuł:
Quality of life in patients with systemic lupus erythematosus (SLE) compared with related controls within a unique African American population.
Autorzy:
Barnado, A
Wheless, L
Meyer, AK
Gilkeson, GS
Kamen, DL
Pokaż więcej
Temat:
SYSTEMIC lupus erythematosus
QUALITY of life
AFRICAN Americans
ECONOMIC history
ECONOMICS
PATIENTS
Źródło:
Lupus; May2012, Vol. 21 Issue 5, p563-569, 7p, 4 Charts
Czasopismo naukowe
Tytuł:
Using Wii Fit to reduce fatigue among African American women with systemic lupus erythematosus: A pilot study.
Autorzy:
Yuen, HK
Holthaus, K
Kamen, DL
Sword, DO
Breland, HL
Pokaż więcej
Temat:
FATIGUE (Physiology)
NINTENDO Wii video games
HEALTH of African American women
SYSTEMIC lupus erythematosus
EXERCISE
PHYSIOLOGY
Źródło:
Lupus; Dec2011, Vol. 20 Issue 12, p1293-1299, 7p, 1 Chart
Czasopismo naukowe
Tytuł:
The United States to Africa lupus prevalence gradient revisited.
Autorzy:
Gilkeson, GS
James, JA
Kamen, DL
Knackstedt, TJ
Maggi, DR
Meyer, AK
Ruth, NM
Pokaż więcej
Temat:
SYSTEMIC lupus erythematosus
DISEASE prevalence
COMPARATIVE studies
GULLAHS
DISEASES in African Americans
SIERRA Leoneans
Źródło:
Lupus; Oct2011, Vol. 20 Issue 10, p1095-1103, 9p, 4 Charts, 2 Maps
Terminy geograficzne:
UNITED States
Czasopismo naukowe
Tytuł:
MicroRNA-3148 modulates differential gene expression of the SLE-associated TLR7variant
Autorzy:
Deng, Y
Zhao, J
Sakurai, D
Kaufman, KM
Edberg, JC
Kimberly, RP
Kamen, DL
Gilkeson, GS
Jacob, CO
Scofield, RH
Langefeld, CD
Kelly, JA
Alarcón-Riquelme, ME
Harley, JB
Vyse, TJ
Freedman, BI
Gaffney, PM
Sivils, KM
James, JA
Niewold, TB
Cantor, RM
Chen, W
Hahn, BH
Brown, EE
Tsao, BP
Pokaż więcej
Źródło:
Arthritis Research & Therapy (formerly Arthritis Research); September 2012, Vol. 14 Issue: Supplement 3
Periodyk
Tytuł:
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort.
Autorzy:
Nguyen Y; National Referral Centre for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP-HP Centre and Université Paris Cité and Centre de Recherche en Epidémiologie et Statistiques (CRESS), Unité Inserm 1153, Université de Paris Cité, Paris, France.
Blanchet B; Biologie du médicament-Toxicologie, AP-HP Centre-Hôpital Cochin, Université Paris Cité, and UMR8038 CNRS, U1268 INSERM, Université Paris Cité, PRES Sorbonne Paris Cité, CARPEM, Paris, France.
Urowitz MB; Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
Hanly JG; Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
Gordon C; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
Bae SC; Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology, and Hanyang University Institute of Bioscience and Biotechnology, Seoul, Korea.
Romero-Diaz J; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.
Sanchez-Guerrero J; Mount Sinai Hospital and University Health Network, University of Toronto, Toronto, Canada.
Clarke AE; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Bernatsky S; McGill University Health Centre, Quebec, Canada.
Wallace DJ; University of California, Los Angeles.
Isenberg DA; University College London, UK.
Rahman A; University College London, UK.
Merrill JT; Oklahoma Medical Research Foundation, Oklahoma City.
Fortin PR; CHU de Québec-Université Laval, Québec City, Canada.
Gladman DD; Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
Bruce IN; NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Center and Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, UK.
Petri M; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Ginzler EM; State University of New York Downstate Medical Center, Brooklyn.
Dooley MA; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill.
Ramsey-Goldman R; Northwestern University and Feinberg School of Medicine, Chicago, Illinois.
Manzi S; Allegheny Health Network, Pittsburgh, Pennsylvania.
Jönsen A; Lund University, Lund, Sweden.
Alarcón GS; University of Alabama at Birmingham Marnix E. Heersink School of Medicine.
Van Vollenhoven RF; University of Amsterdam, Amsterdam, Noord-Holland, The Netherlands.
Aranow C; Feinstein Institute for Medical Research, Manhasset, New York.
Le Guern V; National Referral Centre for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP-HP Centre, Université Paris Cité, Paris, France.
Mackay M; Feinstein Institute for Medical Research, Manhasset, New York.
Ruiz-Irastorza G; BioCruces Bizkaia Health Research Institute, University of the Basque Country, Barakaldo, Spain.
Lim SS; Emory University School of Medicine, Atlanta, Georgia.
Inanc M; Istanbul University, Istanbul, Turkey.
Kalunian KC; University of California San Diego School of Medicine, La Jolla.
Jacobsen S; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Peschken CA; University of Manitoba, Winnipeg, Manitoba, Canada.
Kamen DL; Medical University of South Carolina, Charleston.
Askanase A; Hospital for Joint Diseases and, Seligman Centre for Advanced Therapeutics, New York University, New York City.
Buyon J; New York University School of Medicine, New York City.
Costedoat-Chalumeau N; National Referral Centre for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP-HP Centre and Université Paris Cité and Centre de Recherche en Epidémiologie et Statistiques (CRESS), Unité Inserm 1153, Université de Paris Cité, Paris, France.
Pokaż więcej
Źródło:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Dec; Vol. 75 (12), pp. 2195-2206. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hydroxychloroquine*/therapeutic use
Lupus Erythematosus, Systemic*/drug therapy
Humans ; Female ; Male ; Prednisone ; Immunosuppressive Agents/therapeutic use ; Proportional Hazards Models
Czasopismo naukowe
Tytuł:
Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling.
Autorzy:
Clarke AE; University of Calgary, Calgary, Alberta, Canada.
Hanly JG; Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
Urowitz MB; Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.
St Pierre Y; McGill University Health Center, Montreal, Quebec, Canada.
Gordon C; University of Birmingham, Birmingham, UK.
Bae SC; Hanyang University Hospital for Rheumatic Diseases and Hanyang University, Seoul, Republic of Korea.
Romero-Diaz J; Instituto Nacional de Ciencias Médicas y Nutricion, Mexico City, Mexico.
Sanchez-Guerrero J; Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.
Bernatsky S; McGill University Health Center, Montreal, Quebec, Canada.
Wallace DJ; Cedars-Sinai and University of California, Los Angeles.
Isenberg DA; University College London, London, UK.
Rahman A; University College London, London, UK.
Merrill JT; Oklahoma Medical Research Foundation, Oklahoma City.
Fortin PR; CHU de Québec-Université Laval, Quebec City, Quebec, Canada.
Gladman DD; Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.
Bruce IN; The University of Manchester and Central Manchester University Hospitals National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Petri M; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Ginzler EM; State University of New York Downstate Health Sciences University, Brooklyn.
Dooley MA; University of North Carolina, Chapel Hill.
Ramsey-Goldman R; Northwestern University, Chicago, Illinois.
Manzi S; Alleghany Health Network, Pittsburgh, Pennsylvania.
Jönsen A; Lund University, Lund, Sweden.
Alarcón GS; University of Alabama at Birmingham.
Van Vollenhoven RF; Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Aranow C; Feinstein Institute for Medical Research, Manhasset, New York.
Mackay M; Feinstein Institute for Medical Research, Manhasset, New York.
Ruiz-Irastorza G; University of the Basque Country, Barakaldo, Spain.
Lim SS; Emory University School of Medicine, Atlanta, Georgia.
Inanc M; Istanbul University, Istanbul, Turkey.
Kalunian KC; University of California San Diego, La Jolla.
Jacobsen S; Rigshospitalet and Copenhagen University Hospital, Copenhagen, Denmark.
Peschken CA; University of Manitoba, Winnipeg, Manitoba, Canada.
Kamen DL; Medical University of South Carolina, Charleston.
Askanase A; Hospital for Joint Diseases and New York University Seligman Center for Advanced Therapeutics, New York, New York.
Farewell V; University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło:
Arthritis care & research [Arthritis Care Res (Hoboken)] 2023 Sep; Vol. 75 (9), pp. 1859-1870. Date of Electronic Publication: 2023 Feb 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/therapy
Lupus Erythematosus, Systemic*/complications
Cerebrovascular Disorders*
Humans ; Longitudinal Studies ; Ethnicity ; White
Czasopismo naukowe
Tytuł:
Protocol for virtual physical examination in an observational, longitudinal study evaluating virtual outcome measures in SLE.
Autorzy:
Askanase AD; Division of Rheumatology, Columbia University Irving Medical Center, New York City, New York, USA .
Aranow C; The Center for Autoimmune & Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
Kim MY; Department of Epidemiology & Population Health Division of Biostatistics, Albert Einstein College of Medicine, Bronx, New York, USA.
Kamen DL; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina, USA.
Arriens C; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Khalili L; Division of Rheumatology, Columbia University Irving Medical Center, New York City, New York, USA.
Tang W; Division of Rheumatology, Columbia University Irving Medical Center, New York City, New York, USA.
Barasch J; Division of Rheumatology, Columbia University Irving Medical Center, New York City, New York, USA.
Dall'Era M; Division of Rheumatology, UCSF, San Francisco, California, USA.
Mackay M; The Center for Autoimmune & Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
Pokaż więcej
Źródło:
Lupus science & medicine [Lupus Sci Med] 2023 Jul; Vol. 10 (2).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
COVID-19*
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Humans ; Longitudinal Studies ; Pandemics ; Physical Examination ; Observational Studies as Topic
Czasopismo naukowe
Tytuł:
Evaluating the Construct of Damage in Systemic Lupus Erythematosus.
Autorzy:
Johnson SR; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Gladman DD; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
Brunner HI; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
Isenberg D; University College London Centre for Rheumatology, London, UK.
Clarke AE; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Barber MRW; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Arnaud L; Centre National de Reference des Maladies Autoimmunes et Systemique Rares, INSERM UMR-S 1109, Université de Strasbourg, Strasbourg, France.
Fortin PR; Centre de Recherche du Centre Hospitalier Universitaire de Québec, Faculté de Médecine de l'Université Laval and Centre ARThrite, Quebec City, Quebec, Canada.
Mosca M; University of Pisa, Pisa, Italy.
Voskuyl AE; Amsterdam UMC, VUmc, Amsterdam, The Netherlands.
Manzi S; Allegheny Health Network, Lupus Center of Excellence, Pittsburgh, Pennsylvania.
Aranow C; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.
Askanase A; Columbia University Irving Medical Center, New York, New York.
Alarcón GS; The University of Alabama at Birmingham School of Medicine.
Bae SC; Hanyang University Hospital for Rheumatic Diseases and Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Costedoat-Chalumeau N; Cochin Hospital, Université Paris Descartes-Sorbonne Paris Cité, and INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité, Paris, France.
English JA; Medical University of South Carolina, Charleston.
Pons-Estel GJ; Grupo Oroño, Centro Regional de Enfermedades Autoinmunes y Reumáticas, Sanatorio Parque, Rosario, Argentina.
Pons-Estel BA; Grupo Oroño, Centro Regional de Enfermedades Autoinmunes y Reumáticas, Sanatorio Parque, Rosario, Argentina.
Gilman R; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Ginzler EM; SUNY Downstate Health Sciences University, Brooklyn, New York.
Hanly JG; Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.
Jacobsen S; Copenhagen Lupus and Vasculitis Clinic, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kalunian K; University of California San Diego School of Medicine, La Jolla.
Kamen DL; Medical University of South Carolina, Charleston.
Lambalgen C; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Legge A; Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.
Lim SS; Emory University School of Medicine, Atlanta, Georgia.
Mak A; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Morand EF; Monash University, Melbourne, Victoria, Australia.
Peschken CA; Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Petri M; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Rahman A; University College London Centre for Rheumatology, London, UK.
Ramsey-Goldman R; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Reynolds JA; Institute of Inflammation and Ageing, University of Birmingham and Sandwell and West Birmingham National Health Service Trust, Birmingham, UK.
Romero-Diaz J; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Ruiz-Irastorza G; Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, País Vasco, Spain.
Sanchez-Guerrero J; University Health Network, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada, and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Svenungsson E; Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Touma Z; Institute of Health Policy, Management and Evaluation, Toronto Western and Mount Sinai Hospitals, University of Toronto, Toronto, Ontario, Canada.
Urowitz M; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals, Toronto, Ontario, Canada.
Vinet E; McGill University Faculty of Medicine, Montreal, Quebec, Canada.
van Vollenhoven RF; Amsterdam University Medical Centres, Duivendrecht, Noord-Holland, The Netherlands.
Waldhauser H; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Wallace DJ; Cedars-Sinai Medical Center/David Geffen School of Medicine Center at UCLA, Los Angeles, California.
Zoma A; University Hospital Hairmyres, Lanarkshire, Scotland, UK.
Bruce IN; Manchester University Hospitals National Health Service Foundation Trust, NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, Greater Manchester, UK, Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Pokaż więcej
Źródło:
Arthritis care & research [Arthritis Care Res (Hoboken)] 2023 May; Vol. 75 (5), pp. 998-1006. Date of Electronic Publication: 2022 Dec 20.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Lupus Erythematosus, Systemic*/diagnosis
Rheumatology*
Humans ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey.
Autorzy:
Kamen DL; Department of Medicine, 2629Medical University of South Carolina, Charleston, SC, USA.
Birt JA; Value, Evidence, and Outcomes, 1539Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
Hadi MA; Patient Centred Research, 387388Evidera Inc, London, UK.
Gibbons E; Patient Centred Research, 387388Evidera Inc, London, UK.
Bushnell DM; Patient Centred Research, 387388Evidera Inc, Bethesda, MD, USA.
Yu R; Patient Centred Research, 387388Evidera Inc, London, UK.
Delbecque LA; Value, Evidence, and Outcomes, 1539Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
Griffing K; Value, Evidence, and Outcomes, 1539Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
Askanase A; Department of Rheumatology, 116366Columbia University College of Physicians and Surgeons, New York, NY, USA.
Pokaż więcej
Źródło:
Lupus [Lupus] 2023 Mar; Vol. 32 (3), pp. 342-351. Date of Electronic Publication: 2022 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Fibromyalgia*
Joint Diseases*
Adult ; Humans ; Quality of Life ; Cross-Sectional Studies ; Severity of Illness Index ; Surveys and Questionnaires ; Pain ; Patient Reported Outcome Measures ; Arthralgia
Czasopismo naukowe
Tytuł:
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine.
Autorzy:
Almeida-Brasil CC; Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.
Hanly JG; Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada.
Urowitz M; Schroeder Arthritis Institute, Krembil Research Institute, Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
Clarke AE; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Ruiz-Irastorza G; Autoimmune Diseases Research Unit, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Gordon C; Rheumatology Research Group, University of Birmingham, Birmingham, UK.
Ramsey-Goldman R; Medicine/Rheumatology, Northwestern University, Evanston, Illinois, USA.
Petri MA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ginzler EM; Medicine/Rheumatology, SUNY Downstate Medical Center, New York, New York, USA.
Wallace DJ; Cedars-Sinai/David Geffen School of Medicine at UCLA, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Bae SC; Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology and Hanyang University Institute of Bioscience and Biotechnology, Seoul, Korea.
Romero-Diaz J; Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Dooley MA; Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Peschken C; Rheumatology, University of Manitoba, Winnipeg, Manitoba, Canada.
Isenberg D; Medicine (Rheumatology), University College London, London, UK.
Rahman A; Medicine (Rheumatology), University College London, London, UK.
Manzi S; Allegheny Singer Research Institute, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Jacobsen S; Copenhagen Lupus and Vasculitis Clinic, Copenhagen University Hospital Center for Rheumatology and Spine Diseases, Copenhagen, Denmark.
Lim SS; School of Medicine, Emory University, Atlanta, Georgia, USA.
van Vollenhoven R; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.
Nived O; Department of Clinical Science, Rheumatology, Lund University Faculty of Medicine, Lund, Sweden.
Jönsen A; Department of Clinical Science, Rheumatology, Lund University Faculty of Medicine, Lund, Sweden.
Kamen DL; Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Aranow C; Autoimmune and Musculoskeletal Disease, Feinstein Institute for Medical Research Fertility Research Laboratory, Manhasset, New York, USA.
Sánchez-Guerrero J; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.
Gladman DD; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.
Fortin PR; Medicine-Rheumatology, Universite Laval, Quebec, Quebec, Canada.
Alarcon GS; Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Merrill JT; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Kalunian K; Division of Rheumatology, Allergy and Immunology, University of California San Diego, La Jolla, California, USA.
Ramos-Casals M; Department of Autoimmune Diseases, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Steinsson K; Rheumatology, Department of Obstetrics and Gynecology, Landspitali University Hospital, Reyjavik, Iceland.
Zoma A; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, UK.
Askanase AD; Rheumatology, Columbia University Medical Center, New York, New York, USA.
Khamashta M; Rayne Institute, St Thomas Hospital, London, UK.
Bruce IN; Arc Epidemiology Unit, The University of Manchester, Manchester, UK.
Inanc M; Internal Medicine Rheumatology, Istanbul University, Fatih, Istanbul, Turkey.
Lukusa L; Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.
Bernatsky S; Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Québec, Canada .; Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.
Pokaż więcej
Źródło:
Lupus science & medicine [Lupus Sci Med] 2022 Nov; Vol. 9 (1).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents*/adverse effects
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/epidemiology
Retinal Diseases*/chemically induced
Retinal Diseases*/epidemiology
Humans ; Female ; Aged ; Male ; Hydroxychloroquine/adverse effects ; Chloroquine
Czasopismo naukowe
Tytuł:
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE.
Autorzy:
Kamen DL; Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina, USA.
Wallace C; Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina, USA.
Li Z; Department of Medicine, Division of Hematology/Oncology, Ohio State Wexner Medical Center, Columbus, Ohio, USA.
Wyatt M; Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Paulos C; Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Wei C; University of Rochester Medical Center, Rochester, New York, USA.
Wang H; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Wolf BJ; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Nietert PJ; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Gilkeson G; Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina, USA .
Pokaż więcej
Źródło:
Lupus science & medicine [Lupus Sci Med] 2022 Jul; Vol. 9 (1).
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Mesenchymal Stem Cell Transplantation*/adverse effects
Mesenchymal Stem Cells*
Female ; Humans ; Transforming Growth Factor beta ; Umbilical Cord
Czasopismo naukowe
Tytuł:
Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.
Autorzy:
Ning W; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Cheng D; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; Department of Infectious Disease, Xiangya Hospital, Central South University, Changsha, China.
Howe PH; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, SC, USA.
Bian C; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA.
Kamen DL; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, 114 Doughty Street, Strom Thurmond Research Building Room 416, Charleston, SC, 29403, USA.
Luo Z; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA.
Fu X; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; Department of Infectious Disease, Xiangya Hospital, Central South University, Changsha, China.
Ogunrinde E; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA.
Yang L; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; The Third People's Hospital of Shenzhen, Guangdong, China.
Wang X; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; Department of Urology, Capital Medical University Affiliated XuanWu Hospital, Beijing, China.
Li QZ; Department of Immunology and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Oates J; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, 114 Doughty Street, Strom Thurmond Research Building Room 416, Charleston, SC, 29403, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
Zhang W; Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
White D; Department of Otolaryngology, Medical University of South Carolina, Charleston, SC, USA.
Wan Z; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA.
Gilkeson GS; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, 114 Doughty Street, Strom Thurmond Research Building Room 416, Charleston, SC, 29403, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA. Electronic address: .
Jiang W; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA; Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA. Electronic address: .
Pokaż więcej
Źródło:
Journal of autoimmunity [J Autoimmun] 2022 Jul; Vol. 131, pp. 102860. Date of Electronic Publication: 2022 Jul 08.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Lupus Erythematosus, Systemic*
Staphylococcus aureus*/genetics
Animals ; Antibodies, Antinuclear ; Autoantibodies ; Cell Wall/pathology ; DNA ; Female ; Humans ; Immunoglobulin G ; Immunoglobulin M ; Mice ; Mice, Inbred C57BL ; Mice, Inbred MRL lpr ; Peptidoglycan ; Receptors, Antigen, B-Cell
Czasopismo naukowe
Tytuł:
Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals.
Autorzy:
Munroe ME; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Young KA; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, United States.
Guthridge JM; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.; Department of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, OK, United States.
Kamen DL; Division of Rheumatology, Medical University of South Carolina, Charleston, SC, United States.
Gilkeson GS; Division of Rheumatology, Medical University of South Carolina, Charleston, SC, United States.
Weisman MH; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Ishimori ML; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Wallace DJ; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Karp DR; Division of Rheumatic Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Harley JB; US Department of Veterans Affairs Medical Center, Cincinnati, OH, United States.
Norris JM; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, United States.
James JA; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.; Department of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, OK, United States.; Department of Pathology, Oklahoma University Health Sciences Center, Oklahoma City, OK, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Jun 03; Vol. 13, pp. 866181. Date of Electronic Publication: 2022 Jun 03 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Autoimmunity*
Lupus Erythematosus, Systemic*
Autoantibodies ; Humans ; Inflammation ; Interleukin-10 ; Self Report ; Surveys and Questionnaires ; Transforming Growth Factor beta
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies